Adefovir Dipivoxil Patent Expiration
Adefovir Dipivoxil is Used for treating chronic hepatitis B virus infection. It was first introduced by Gilead Sciences Inc
Adefovir Dipivoxil Patents
Given below is the list of patents protecting Adefovir Dipivoxil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Hepsera | US6451340 | Nucleotide analog compositions |
Jul 23, 2018
(Expired) | Gilead |
| Hepsera | US5663159 | Prodrugs of phosphonates |
Sep 02, 2014
(Expired) | Gilead |
Adefovir Dipivoxil's Family Patents
Explore Our Curated Drug Screens
Adefovir Dipivoxil Generic API Manufacturers
Several generic applications have been filed for Adefovir Dipivoxil. The first generic version for Adefovir Dipivoxil was by Sigmapharm Laboratories Llc and was approved on Aug 29, 2013. And the latest generic version is by Apotex Inc and was approved on Jul 6, 2018.
Given below is the list of companies who have filed for Adefovir Dipivoxil generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 1 generic for Adefovir Dipivoxil. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jul 6, 2018 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
2. SIGMAPHARM LABS LLC
Sigmapharm Laboratories Llc has filed for 1 generic for Adefovir Dipivoxil. Given below are the details of the strengths of this generic introduced by Sigmapharm Labs Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG
(reference standard) | tablet | Prescription | ORAL | AB | Aug 29, 2013 |